Avior Wealth Management LLC Invests $40,000 in Encompass Health Co. (NYSE:EHC)

Avior Wealth Management LLC purchased a new position in Encompass Health Co. (NYSE:EHC) in the 3rd quarter, Holdings Channel.com reports. The firm purchased 418 shares of the company’s stock, valued at approximately $40,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. CIBC Asset Management Inc boosted its stake in shares of Encompass Health by 3.5% in the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock valued at $286,000 after purchasing an additional 100 shares in the last quarter. Commonwealth Equity Services LLC grew its stake in Encompass Health by 1.3% during the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company’s stock worth $845,000 after buying an additional 123 shares during the last quarter. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares in the last quarter. O Shaughnessy Asset Management LLC raised its stake in shares of Encompass Health by 3.9% in the first quarter. O Shaughnessy Asset Management LLC now owns 4,246 shares of the company’s stock valued at $351,000 after acquiring an additional 160 shares during the last quarter. Finally, Verdence Capital Advisors LLC boosted its holdings in shares of Encompass Health by 4.6% in the 3rd quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock worth $355,000 after acquiring an additional 160 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Up 0.9 %

NYSE:EHC opened at $102.00 on Tuesday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 12-month low of $63.78 and a 12-month high of $104.55. The stock’s fifty day simple moving average is $97.28 and its 200-day simple moving average is $90.99. The firm has a market capitalization of $10.28 billion, a P/E ratio of 24.64, a P/E/G ratio of 1.34 and a beta of 0.88.

Encompass Health (NYSE:EHC) last posted its earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.86 EPS. Equities research analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. Encompass Health’s dividend payout ratio is 16.43%.

Analysts Set New Price Targets

Several equities analysts have issued reports on EHC shares. KeyCorp lifted their price objective on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. UBS Group upped their price target on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Truist Financial restated a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Barclays upped their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Finally, Stephens reissued an “overweight” rating and issued a $105.00 price target on shares of Encompass Health in a report on Tuesday, August 6th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.